Growth Metrics

Ginkgo Bioworks Holdings (DNA) Income from Continuing Operations: 2019-2024

Historic Income from Continuing Operations for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Dec 2024 value amounting to -$547.0 million.

  • Ginkgo Bioworks Holdings' Income from Continuing Operations fell 43.18% to -$80.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$339.5 million, marking a year-over-year increase of 47.86%. This contributed to the annual value of -$547.0 million for FY2024, which is 38.73% up from last year.
  • Ginkgo Bioworks Holdings' Income from Continuing Operations amounted to -$547.0 million in FY2024, which was up 38.73% from -$892.9 million recorded in FY2023.
  • In the past 5 years, Ginkgo Bioworks Holdings' Income from Continuing Operations registered a high of -$126.7 million during FY2020, and its lowest value of -$2.1 billion during FY2022.
  • Its 3-year average for Income from Continuing Operations is -$1.2 billion, with a median of -$892.9 million in 2023.
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' Income from Continuing Operations plummeted by 1,349.34% in 2021, and later skyrocketed by 57.61% in 2023.
  • Yearly analysis of 5 years shows Ginkgo Bioworks Holdings' Income from Continuing Operations stood at -$126.7 million in 2020, then plummeted by 1,349.34% to -$1.8 billion in 2021, then decreased by 14.69% to -$2.1 billion in 2022, then soared by 57.61% to -$892.9 million in 2023, then skyrocketed by 38.73% to -$547.0 million in 2024.